At Living DNA, your privacy and the security of your data are our top priorities. To enhance the protection of your account, as of December 2024 we are introducing two-factor authentication (2FA) for all users.
What is Two-Factor Authentication?
Two-factor authentication adds an extra layer of security to your account by requiring two forms of verification to log in. After entering your username and password, you will be prompted to enter a unique six-digit code sent to your registered email address.
This simple yet effective process ensures that only you can access your account, even if someone else knows or has guessed your password.
How does it work?
- Log in as usual: Enter your username and password on the Living DNA portal.
- Check your email: You will automatically receive an email containing a six-digit numeric code.
- Enter the code: Input the code on the login screen to complete your login.
Once verified, you will be granted access to your account and results.
Why are we introducing 2FA?
Two-factor authentication significantly reduces the risk of unauthorised access to your account. It ensures that your sensitive information, including your DNA and health information, is protected with the highest security standards.
Frequently Asked Questions
- What if I don’t receive the email with the code?
If you don’t see the email within a few minutes, go through the following steps:
- Check your spam or junk folder.
- Ensure that the email address you entered is correct.
- Contact the Living DNA support team for assistance.
- Will I need to use 2FA every time I log in?
Yes, you will be required to enter a new code at each login to ensure consistent security.
- What happens if I lose access to my registered email address?
If you no longer have access to your email, contact our support team immediately. We will help you to update your email address securely.
- Can I opt out of 2FA?
Two-factor-aurthentication is mandatory for all Living DNA accounts to maintain the highest security standards.
Comments
0 comments
Article is closed for comments.